MASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (MASH) here
Search
Scleroderma
Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs
Dog parasites: What you should know
Dog parasites: What you should know
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations.
Heart Failure
Heart Failure
Our Countries
Our Countries
Data Privacy-Pharmacovigilance in Animal Health
Data Privacy Notice for Pharmacovigilance in Animal Health
COPD
COPD
Data Protection Notice Members Healthcare Professions
Data Protection Notice Members Healthcare Professions
Biotherapeutics Discovery
Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Chronic Kidney Disease
Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.
Horses
Horses
Research Beyond Borders
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Small Molecule Drug Discovery
Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve.
Data Protection Notice Medical Inquiries
Data Protection Notice Medical Inquiries
Data Privacy-Pharmacovigilance Humanpharma
Data Privacy-video surveillance at Boehringer Ingelheim
Data Protection Notice for video surveillance
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
The Oscars of Science
Revolutionary advances in physics and chemistry used at Boehringer Ingelheim
Data Protection Notice RCV Countries
Data Protection Notice RCV Countries
Depression
Depression
Boehringer Ingelheim_Five ways to include more diversity in clinical trials
Cancer cell directed therapies
At Boehringer Ingelheim, we are investigating cancer cell directed therapies that target key cancer drivers and hallmarks to directly kill cancer cells.
Human Health Partnering
Human Health Partnering
Research Institute of Molecular Pathology IMP
Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria.